Profil
Robin D.
Campbell's career history includes current and former positions as well as education.
Currently, Dr. Campbell is the Chairman at Aptitude Medical Systems, Inc. In the past, Dr. Campbell held positions such as President & Chief Executive Officer at Naryx Pharma, Inc. from 2004 to 2008, Director at SEQUUS Pharmaceuticals, Inc. from 1998 to 1999, Director at SymBio Pharmaceuticals Ltd. from 2018 to 2019, and Independent Director at Pelican Inc. from 2014 to 2020.
Dr. Campbell also served as a Director at Acelot, Inc. and held various roles at Amgen, Inc. from 1989 to 2002, including VP-US Oncology Business Unit & General Manager.
Additionally, Dr. Campbell was a Principal at Ciba-Geigy Corp.
and served as President at Kirin-Amgen, Inc. from 1997 to 2000.
Dr. Campbell's education includes a doctorate from Wake Forest School of Medicine and an undergraduate degree from The University of North Carolina at Charlotte.
Postes actifs de Robin D. Campbell
| Sociétés | Poste | Début |
|---|---|---|
Aptitude Medical Systems, Inc.
Aptitude Medical Systems, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biotechnical research services | Président | 01/12/2011 |
Anciens postes connus de Robin D. Campbell
| Sociétés | Poste | Fin |
|---|---|---|
| PFENEX INC. | Directeur/Membre du Conseil | 01/10/2020 |
| SYMBIO PHARMACEUTICALS LIMITED | Directeur/Membre du Conseil | 01/03/2019 |
Naryx Pharma, Inc.
Naryx Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops products for the treatment of chronic sinusitis | Directeur Général | 01/01/2008 |
| AMGEN INC. | Corporate Officer/Principal | 01/01/2002 |
Kirin-Amgen, Inc.
Kirin-Amgen, Inc. Pharmaceuticals: MajorHealth Technology Manufacture pharmaceutical drugs and provides licensing | President | 01/01/2000 |
Formation de Robin D. Campbell
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Ciba-Geigy Corp.
Ciba-Geigy Corp. Medical SpecialtiesHealth Technology Manufactures physician and surgical equipment | Health Technology |
SEQUUS Pharmaceuticals, Inc.
SEQUUS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Markets lipid-based biopharmaceutical products mainly to treat cancer and infectious diseases | Health Technology |
Wake Forest School of Medicine
Wake Forest School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Naryx Pharma, Inc.
Naryx Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops products for the treatment of chronic sinusitis | Health Technology |
SymBio Pharmaceuticals Ltd.
SymBio Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapeutics for cancer and other related diseases | Health Technology |
Kirin-Amgen, Inc.
Kirin-Amgen, Inc. Pharmaceuticals: MajorHealth Technology Manufacture pharmaceutical drugs and provides licensing | Health Technology |
Pelican Inc
Pelican Inc Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical therapeutics and vaccines | Health Technology |
The University of North Carolina at Charlotte
The University of North Carolina at Charlotte Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aptitude Medical Systems, Inc.
Aptitude Medical Systems, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biotechnical research services | Commercial Services |
Acelot, Inc.
Acelot, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on AI-driven drug discovery and development of therapies for neurodegenerative diseases | Health Technology |
















